Abstract
Purpose
Pediatric patients with intestinal failure need long-term parenteral nutrition (PN), but this nutritional support causes liver dysfunction, such as intestinal failure-associated liver disease (IFALD). Several studies have shown that the lipid emulsion produced by soybean oil (SO) is associated with the occurrence of IFALD. In this study, we evaluated the effect of SO and fish oil (FO) lipid emulsion on hepatic steatosis.
Methods
Sprague-Dawley rats underwent jugular vein catheterization and were divided into three groups: sham operation with normal chow (Sham group), 80% small bowel resection (80% SBR) + TPN with SO lipid emulsion (SO group), and 80% SBR + TPN with FO lipid emulsion (FO group). All rats were euthanized and the serum biochemistry and hepatic histology analyzed.
Results
No significant differences in the serum liver or biliary enzymes were noted between the SO and FO groups. The pathological findings and NAFLD score in the FO group did not show steatosis and were significantly lower than in the SO group. An analysis of the fatty acids profile in the both the SO and FO groups did not indicate essential fatty acid deficiency (EFAD).
Conclusion
FO lipid emulsion may have a protective role against steatosis of IFALD without EFAD.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00383-017-4190-4/MediaObjects/383_2017_4190_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00383-017-4190-4/MediaObjects/383_2017_4190_Fig2_HTML.gif)
Similar content being viewed by others
References
Kelly DA (2006) Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130(2 Suppl 1):S70–77. doi:10.1053/j.gastro.2005.10.066
Kelly DA (1998) Liver complications of pediatric parenteral nutrition—epidemiology. Nutrition 14(1):153–157
Wilmore DW, Groff DB, Bishop HC, Dudrick SJ (1969) Total parenteral nutrition in infants with catastrophic gastrointestinal anomalies. J Pediatr Surg 4(2):181–189
Nandivada P, Cowan E, Carlson SJ, Chang M, Gura KM, Puder M (2013) Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease. Prostaglandin Leukot Essent Fat Acids 89(4):153–158. doi:10.1016/j.plefa.2013.02.008
de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M (2010) Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg 145(6):547–551. doi:10.1001/archsurg.2010.80
Wales PW, Allen N, Worthington P, George D, Compher C, American Society for P, Enteral N, Teitelbaum D (2014) A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. JPEN J Parenter Enter Nutr 38(5):538–557. doi:10.1177/0148607114527772
Nawata A, Noguchi H, Mazaki Y, Kurahashi T, Izumi H, Wang KY, Guo X, Uramoto H, Kohno K, Taniguchi H, Tanaka Y, Fujii J, Sasaguri Y, Tanimoto A, Nakayama T, Yamada S (2016) Overexpression of peroxiredoxin 4 affects intestinal function in a dietary mouse model of nonalcoholic fatty liver disease. PloS One 11(4):e0152549. doi:10.1371/journal.pone.0152549
Holman RT, Smythe L, Johnson S (1979) Effect of sex and age on fatty acid composition of human serum lipids. Am J Clin Nutr 32(12):2390–2399
Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R, Parenteral Nutrition Guidelines Working G, European Society for Clinical N, Metabolism, European Society of Paediatric Gastroenterology Nutrition H, European Society of Paediatric R (2005) Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 41(Suppl 2):S1–87
Chen WJ, Yeh SL, Huang PC (1996) Effects of fat emulsions with different fatty acid composition on plasma and hepatic lipids in rats receiving total parenteral nutrition. Clin Nutr 15(1):24–28
Park Y, Harris WS (2003) Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44(3):455–463. doi:10.1194/jlr.M200282-JLR200
Gura KM, Parsons SK, Bechard LJ, Henderson T, Dorsey M, Phipatanakul W, Duggan C, Puder M, Lenders C (2005) Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 24(5):839–847. doi:10.1016/j.clnu.2005.05.020
Das UN (2006) Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 1(4):420–439. doi:10.1002/biot.200600012
Meisel JA, Le HD, de Meijer VE, Nose V, Gura KM, Mulkern RV, Akhavan Sharif MR, Puder M (2011) Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg 46(4):666–673. doi:10.1016/j.jpedsurg.2010.08.018
Venick RS, Calkins K (2011) The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease. Curr Opin Org Transpl 16(3):306–311. doi:10.1097/MOT.0b013e32834670eb
Calkins KL, Dunn JC, Shew SB, Reyen L, Farmer DG, Devaskar SU, Venick RS (2014) Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil. JPEN J Parenter Enter Nutr 38(6):682–692. doi:10.1177/0148607113495416
Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM (2009) Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 250(3):395–402. doi:10.1097/SLA.0b013e3181b36657
Bays HE (2007) Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 99(6A):35C–43C. doi:10.1016/j.amjcard.2006.11.020
Davis-Bruno K, Tassinari MS (2011) Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. Birth Defect Res Part B Dev Reprod Toxicol 92(3):240–250. doi:10.1002/bdrb.20311
Acknowledgements
We thank Brian Quinn for his comments and help with the manuscript. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 16K10466, 16K10094, 16K10095, 16K10434, 16H07090, 17K10555, 17K11514, 17K10183, 17K11515, and 17K10180).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest in association with the present study.
Rights and permissions
About this article
Cite this article
Machigashira, S., Kaji, T., Onishi, S. et al. The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome. Pediatr Surg Int 34, 203–209 (2018). https://doi.org/10.1007/s00383-017-4190-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-017-4190-4